{"name":"MANA RBM","slug":"mana-rbm","ticker":"","exchange":"","domain":"","description":"MANA RBM is a biopharmaceutical company focused on developing innovative treatments primarily in the field of oncology. The company has a pipeline of six drugs, though all are currently in discontinued phases, indicating a strategic shift or challenges in their development process.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNUHJDOWRCVkUxRkdzQXZSeng5ckNqd1JqUDZyZlBCQVZpSG5tYnJZUDYtTDFWZER2OGhLcXFyMmRuMTlPaFFFWDBwcC1pRlRjMW9LcmpCd2tmUThGMnY2Ql9WcHZtQnhYYjBRN045OTByX0loZEZWZ181Rk80QnVTZ1UtYw?oc=5","date":"2022-09-06","type":"pipeline","source":"Pharma Voice","summary":"Entrepreneurs: Dr. Penelope Manasco - Pharma Voice","headline":"Entrepreneurs: Dr. Penelope Manasco","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxObWN1VFNuYVdlMzFTOWxJVXcyOVdtRGFmSUNZMGF4MVpiNm05aXcwcnBrc0ktaC1sREFFRHFfcVBKUnJTNmtGSEplOXNPTVRyR1diOGZpRVc1TkdaMFVxVlpQZ3N2TkRydHBxR0I1N1ZTNy1MUFpxbS0zLVNndWJzNE5VSUxsQzhvNlRSSlRrTDB3UQ?oc=5","date":"2020-08-09","type":"trial","source":"Applied Clinical Trials","summary":"Risk-Based Monitoring: Barriers to Adoption - Applied Clinical Trials","headline":"Risk-Based Monitoring: Barriers to Adoption","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQb3loanFCNDVPMHdTVzNqQnZ2REJBYWFST3NpZGxFVWNseVpWRnhwdkgxLXkzeDh0WUJ2QVdxWjMzX0JjR3AxZ2RvR21HWnlwN0dlX0xTVEtfUHhoRVBCeE9PQTdySmJXOGFHUFRpa1otZ1Z3eUxrc3ZiZUpIYVE0bXZNdlN0cXYwUUoxcVFRMnRRTjFQR3ZrQlpmLTN5NFoybjB2b08xUXRvQWppQ24yYUpFWUw3QQ?oc=5","date":"2018-09-28","type":"trial","source":"Applied Clinical Trials","summary":"Comparing Risk Based Monitoring and Remote Trial Management vs. SDV - Applied Clinical Trials","headline":"Comparing Risk Based Monitoring and Remote Trial Management vs. SDV","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}